NEO
Price
$16.83
Change
+$0.34 (+2.06%)
Updated
Nov 3 closing price
Capitalization
2.16B
112 days until earnings call
Intraday BUY SELL Signals
TMDX
Price
$67.34
Change
+$0.67 (+1.00%)
Updated
Nov 3 closing price
Capitalization
2.34B
2 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

NEO vs TMDX

NEO vs TMDX Comparison Chart in %
View a ticker or compare two or three
VS
NEO vs. TMDX commentary
Nov 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NEO is a Buy and TMDX is a Hold.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for NEO with price predictions
Nov 02, 2026

Aroon Indicator for NEO shows an upward move is likely

NEO's Aroon Indicator triggered a bullish signal on September 30, 2026. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 189 similar instances where the Aroon Indicator showed a similar pattern. In 156 of the 189 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at 83%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 20, 2026. You may want to consider a long position or call options on NEO as a result. In 70 of 86 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 81%.

The Moving Average Convergence Divergence (MACD) for NEO just turned positive on October 27, 2026. Looking at past instances where NEO's MACD turned positive, the stock continued to rise in 36 of 48 cases over the following month. The odds of a continued upward trend are 75%.

Following a +7.79% 3-day Advance, the price is estimated to grow further. Considering data from situations where NEO advanced for three days, in 215 of 277 cases, the price rose further within the following month. The odds of a continued upward trend are 78%.

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 43 of 55 cases where NEO's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 78%.

NEO moved below its 50-day moving average on October 30, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for NEO crossed bearishly below the 50-day moving average on October 12, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 8 of 11 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 73%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where NEO declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 81%.

NEO broke above its upper Bollinger Band on October 28, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 27 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.752) is normal, around the industry mean (65.876). P/E Ratio (-43.154) is within average values for comparable stocks, (3.542). Projected Growth (PEG Ratio) (0.060) is also within normal values, averaging (3.473). Dividend Yield (0.000) settles around the average of (0.002) among similar stocks. P/S Ratio (3.189) is also within normal values, averaging (9.775).

The Tickeron Price Growth Rating for this company is 37 (best 1 - 100 worst), indicating steady price growth. NEO’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of 44 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron PE Growth Rating for this company is 66 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 92 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. NEO’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 86, placing this stock worse than average.

A.I.Advisor
a Summary for TMDX with price predictions
Nov 02, 2026

TMDX's Indicator enters downward trend

The Aroon Indicator for TMDX entered a downward trend on November 02, 2026. Tickeron's A.I.dvisor identified a pattern where the AroonDown red line was above 70 while the AroonUp green line was below 30 for three straight days. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options. A.I.dvisor looked at 164 similar instances where the Aroon Indicator formed such a pattern. In 140 of the 164 cases the stock moved lower. This puts the odds of a downward move at 85%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on September 28, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on TMDX as a result. In 70 of 85 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 82%.

TMDX moved below its 50-day moving average on September 28, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for TMDX crossed bearishly below the 50-day moving average on October 01, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 13 of 18 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 72%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where TMDX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 80%.

Bullish Trend Analysis

The RSI Indicator shows that the ticker has stayed in the oversold zone for 3 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 5 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a +5.61% 3-day Advance, the price is estimated to grow further. Considering data from situations where TMDX advanced for three days, in 258 of 306 cases, the price rose further within the following month. The odds of a continued upward trend are 84%.

TMDX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is 28 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of 67 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.507) is normal, around the industry mean (4.170). P/E Ratio (15.133) is within average values for comparable stocks, (1.500). Projected Growth (PEG Ratio) (0.709) is also within normal values, averaging (11.253). Dividend Yield (0.000) settles around the average of (0.010) among similar stocks. P/S Ratio (5.033) is also within normal values, averaging (40.124).

The Tickeron Profit vs. Risk Rating rating for this company is 79 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. TMDX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock better than average.

The Tickeron Price Growth Rating for this company is 80 (best 1 - 100 worst), indicating slightly worse than average price growth. TMDX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is 95 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

FUNDAMENTALS RATINGS
NEO vs TMDX: Fundamental Ratings
NEO
TMDX
OUTLOOK RATING
1..100
2669
VALUATION
overvalued / fair valued / undervalued
1..100
27
Undervalued
67
Overvalued
PROFIT vs RISK RATING
1..100
10079
SMR RATING
1..100
9228
PRICE GROWTH RATING
1..100
3780
P/E GROWTH RATING
1..100
6695
SEASONALITY SCORE
1..100
4450

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

NEO's Valuation (27) in the Medical Or Nursing Services industry is somewhat better than the same rating for TMDX (67) in the Medical Specialties industry. This means that NEO’s stock grew somewhat faster than TMDX’s over the last 12 months.

TMDX's Profit vs Risk Rating (79) in the Medical Specialties industry is in the same range as NEO (100) in the Medical Or Nursing Services industry. This means that TMDX’s stock grew similarly to NEO’s over the last 12 months.

TMDX's SMR Rating (28) in the Medical Specialties industry is somewhat better than the same rating for NEO (92) in the Medical Or Nursing Services industry. This means that TMDX’s stock grew somewhat faster than NEO’s over the last 12 months.

NEO's Price Growth Rating (37) in the Medical Or Nursing Services industry is somewhat better than the same rating for TMDX (80) in the Medical Specialties industry. This means that NEO’s stock grew somewhat faster than TMDX’s over the last 12 months.

NEO's P/E Growth Rating (66) in the Medical Or Nursing Services industry is in the same range as TMDX (95) in the Medical Specialties industry. This means that NEO’s stock grew similarly to TMDX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
NEOTMDX
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
78%
Bullish Trend 2 days ago
75%
Momentum
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 7 days ago
82%
MACD
ODDS (%)
Bullish Trend 2 days ago
75%
N/A
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
80%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
84%
Advances
ODDS (%)
Bullish Trend 7 days ago
78%
Bullish Trend 15 days ago
84%
Declines
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 7 days ago
80%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
73%
Bullish Trend 2 days ago
88%
Aroon
ODDS (%)
Bullish Trend 5 days ago
83%
Bearish Trend 2 days ago
85%
COMPARISON
Comparison
Nov 04, 2026
Stock price -- (NEO: $16.49 vs. TMDX: $66.67)
Brand notoriety: NEO and TMDX are both not notable
NEO represents the Medical Specialties, while TMDX is part of the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: NEO: 84% vs. TMDX: 82%
Market capitalization -- NEO: $2.12B vs. TMDX: $2.31B
NEO [@Medical Specialties] is valued at $2.12B. TMDX’s [@Medical/Nursing Services] market capitalization is $2.31B. The market cap for tickers in the [@Medical Specialties] industry ranges from $27 to $4.39T. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $837 to $190.62B. The average market capitalization across the [@Medical Specialties] industry is $21.35B. The average market capitalization across the [@Medical/Nursing Services] industry is $5.88B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NEO’s FA Score shows that 1 FA rating(s) are green while TMDX’s FA Score has 1 green FA rating(s).

  • NEO’s FA Score: 1 green, 4 red.
  • TMDX’s FA Score: 1 green, 4 red.
According to our system of comparison, NEO is a better buy in the long-term than TMDX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NEO’s TA Score shows that 4 TA indicator(s) are bullish while TMDX’s TA Score has 4 bullish TA indicator(s).

  • NEO’s TA Score: 4 bullish, 5 bearish.
  • TMDX’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, both NEO and TMDX are a bad buy in the short-term.

Price Growth

NEO (@Medical Specialties) experienced а -1.20% price change this week, while TMDX (@Medical/Nursing Services) price change was -5.61% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -2.34%. For the same industry, the average monthly price growth was -5.26%, and the average quarterly price growth was +42.07%.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was +0.01%. For the same industry, the average monthly price growth was -6.09%, and the average quarterly price growth was -8.21%.

Reported Earning Dates

NEO is expected to report earnings on Feb 23, 2027.

TMDX is expected to report earnings on Nov 05, 2026.

Industries' Descriptions

@Medical Specialties (-2.34% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

@Medical/Nursing Services (+0.01% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

View a ticker or compare two or three
NEO
Daily Signal:
Gain/Loss:
TMDX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement

NEO and

Correlation & Price change

A.I.dvisor indicates that over the last year, NEO has been loosely correlated with NTRA. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if NEO jumps, then NTRA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NEO
1D Price
Change %
NEO100%
+2.06%
NTRA - NEO
55%
Loosely correlated
+2.56%
ADPT - NEO
53%
Loosely correlated
+2.95%
CSTL - NEO
47%
Loosely correlated
+0.57%
RVTY - NEO
46%
Loosely correlated
+7.84%
SHC - NEO
44%
Loosely correlated
-9.64%
More

TMDX and

Correlation & Price change

A.I.dvisor indicates that over the last year, TMDX has been loosely correlated with ATEC. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if TMDX jumps, then ATEC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TMDX
1D Price
Change %
TMDX100%
+1.00%
ATEC - TMDX
39%
Loosely correlated
+2.19%
PODD - TMDX
37%
Loosely correlated
+0.81%
RDNT - TMDX
35%
Loosely correlated
+0.11%
SMTI - TMDX
34%
Loosely correlated
+0.31%
ALGN - TMDX
33%
Loosely correlated
-1.65%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
KLIP21.200.26
+1.24%
KraneShares KWEB Covered Call Strategy ETF (KLIP)
IFLN17.490.04
+0.23%
Invesco Bloomberg Enhanced Fallen Angels ETF (IFLN)
DDXX27.78N/A
N/A
Defined Duration 20 ETF (DDXX)
GEMG3.52N/A
N/A
Leverage Shares 2X Long GEMI Daily ETF (GEMG)
OAKM31.28-0.17
-0.54%
Oakmark U.S. Large Cap ETF